Retrospective post-marketing study on the use of bio-similar pegasparagase among acute lymphoblastic leukemia patients in India
Background: Acute lymphoblastic leukemia (ALL) is a cancer of lymphoid progenitor cells with highest incidence among children aged 2–3 years. Pegaspargase, the PEGylated form of L-asparaginase (PEG-ASP) is a component of multidrug regimens used in the management of ALL. Data on experience of PEG-ASP...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-03-01
|
| Series: | Pediatric Hematology Oncology Journal |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468124517301031 |